search
Back to results

Mini-PNL, RIRS, and ESWL for Treatment of Medium-Sized, High-Density, Non-Lower Pole, Renal Stones

Primary Purpose

Renal Stone, Percutaneous Nephrolithotomy, Retrograde Intrarenal Surgery

Status
Recruiting
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
mini-PNL
RIRS
SWL
Sponsored by
Al-Azhar University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Renal Stone

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Adult patients (both genders)
  • Single non-lower pole renal stone.
  • Stone size: 10-20 mm.
  • Stone density: > 1000 HU.

Exclusion Criteria:

  • Pregnant women.
  • Morbid obesity.
  • Severe orthopaedic deformities.
  • Co-morbidities precluding general anaesthesia or prone positioning.
  • Uncorrectable coagulation disorders.
  • Active urinary tract infection (UTI).
  • Stone in a calyceal diverticulum.
  • Abnormal renal anatomy.
  • Urinary tract obstruction distal to the stone.
  • Concomitant pathology that needs intervention in the same setting.
  • Advanced hydronephrosis.

Sites / Locations

  • Urology Department, Al-Azhar University HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Experimental

Arm Label

mini-PNL group

RIRS group

SWL group

Arm Description

In which PCNL will be performed using miniature nephroscope

In which RIRS will be performed using a flexible ureteroscope

In which extracorporeal shock wave lithotripsy will be performed using Dornier lithotripter SII

Outcomes

Primary Outcome Measures

Stone-free rate
Stone free status is defined as no residual renal stone or residual fragment(s) less than 4 mm size.
Complication rate
intra- and post-operative complications

Secondary Outcome Measures

Cost of treatment
The cost of each treatment methods will be estimated, Including the devices, disposable instruments, operating room, bed stay, imaging, laboratory, medications, retreatment and ancillary procedures.
Patients satisfaction
A 5-point scale will be used to assess satisfaction, where 1 is unsatisfied and 5 fully satisfied.
Surgeon's satisfaction.
A 5-point scale will be used to assess satisfaction, where 1 is unsatisfied and 5 fully satisfied.

Full Information

First Posted
April 17, 2021
Last Updated
February 10, 2023
Sponsor
Al-Azhar University
search

1. Study Identification

Unique Protocol Identification Number
NCT04856722
Brief Title
Mini-PNL, RIRS, and ESWL for Treatment of Medium-Sized, High-Density, Non-Lower Pole, Renal Stones
Official Title
Mini-PNL, RIRS, and ESWL for Treatment of Medium-Sized, High-Density, Non-Lower Pole, Renal Stones: A Prospective, Randomized, Comparative Study
Study Type
Interventional

2. Study Status

Record Verification Date
February 2023
Overall Recruitment Status
Recruiting
Study Start Date
April 5, 2021 (Actual)
Primary Completion Date
April 1, 2023 (Anticipated)
Study Completion Date
May 1, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Al-Azhar University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The optimal management of medium-sized renal stones remains quite challenging and continues to be contested. In the present study, the investigators will compare mini-PNL, RIRS and SWL in the treatment of non- lower pole, medium size, high dense renal stones regarding the stone-free rate, the safety of the procedures, cost, and patients' and surgeon's satisfaction. Eligible patients will be randomly allocated into three equal groups (mini-PNL, RIRS, and SWL). Postoperative, patients will be followed-up by regularly for 3 months. The study parameters will be compared between groups.
Detailed Description
The treatment options for renal stones 10-20 mm include either extracorporeal shock wave lithotripsy (SWL) or endourology (retrograde intrarenal surgery (RIRS) and percutaneous nephrolithotomy (PNL). SWL is an attractive treatment option for renal stones because it is non-invasive and more acceptable for the patient and can be done under analgesia, sedation, or minimal anaesthesia. However, the limitation of SWL includes a relatively lower stone-free rate (SFR) and the need for repeated sessions and auxiliary procedures. The SFR after SWL is affected by several factors, including body mass index (BMI), stone size, intrarenal stone location, skin-to-stone distance (SSD), and stone density. The EAU guidelines put endourology and SWL as two equal options in medium-sized non-lower pole renal stones and did not give special attention to the stone density, which is an important predictor for SWL outcome. Several studies reported that the number of SWL sessions increased with increased stone attenuation value (SAV) and SFR decreased significantly in high-density renal stone. PNL and RIRS have good SFR compared to SWL but might entail a significant risk of morbidity. The improved fURS instrumentation and lithotripsy technology, and development of the miniaturized PNL technique, may lower the procedure-related complications and mPNL and RIRS an alternative and excellent option for medium-sized and even large renal stones The investigators hypothesize that addressing the stone density factor may give a clear recommendation for medium-sized, high-density renal stones. They expected the superiority for either mPNL or RIRS, regarding SFR, without increased morbidity. The study aims to compare the outcome of mPNL, RIRS, and SWL for treatment of non-lower pole, high-density renal stones of 10 to 20 mm size. The study will include adult patients with non-lower pole, high-density (>1000 HU) renal stones of 10 to 20 mm size. Pre-operatively, patients will be evaluated by medical history taking, physical examination. urinalysis, urine culture, complete blood cell count (CBC), liver function tests, coagulation profile, blood urea nitrogen (BUN), serum creatinine, plain abdominal X-ray and computed tomography for urinary tract (CT-UT), Eligible patients will be randomly divided into 3 equal groups. PNL group, in which PNL procedures will be performed using miniature nephroscope, RIRS group, in which RIRS will be performed using flexible ureteroscope and SWL group, in which SWL procedures will be performed using Dornier Lithotripter. post-operatively, patients will be followed up regularly, for 3 months. The SFR, complication rate, cost, patients' and surgeon's satisfaction will be evaluated and compared between the three groups using the appropriate statistical tests and analytical program.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Renal Stone, Percutaneous Nephrolithotomy, Retrograde Intrarenal Surgery, Extracorporeal Shockwave Lithotripsy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
180 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
mini-PNL group
Arm Type
Experimental
Arm Description
In which PCNL will be performed using miniature nephroscope
Arm Title
RIRS group
Arm Type
Experimental
Arm Description
In which RIRS will be performed using a flexible ureteroscope
Arm Title
SWL group
Arm Type
Experimental
Arm Description
In which extracorporeal shock wave lithotripsy will be performed using Dornier lithotripter SII
Intervention Type
Procedure
Intervention Name(s)
mini-PNL
Intervention Description
PCNL using miniature nephroscope. The procedure will be performed under general or regional anaesthesia under fluoroscopy guidance.
Intervention Type
Procedure
Intervention Name(s)
RIRS
Intervention Description
RIRS using flexible ureteroscope. The procedure will be performed under general or regional anaesthesia under fluoroscopy guidance. Holmium Laser lithotripter will be used for stone fragmentation.
Intervention Type
Procedure
Intervention Name(s)
SWL
Intervention Description
SWL using Dornier SII lithotripter. the procedure will be performed under sedoanalgesia, and fluoroscopy will be used for stone localization; for a maximum of 3 SWL session.
Primary Outcome Measure Information:
Title
Stone-free rate
Description
Stone free status is defined as no residual renal stone or residual fragment(s) less than 4 mm size.
Time Frame
as detected by non-contrasted computed tomography 3 months after the intervention procedures.
Title
Complication rate
Description
intra- and post-operative complications
Time Frame
up to 3 months.
Secondary Outcome Measure Information:
Title
Cost of treatment
Description
The cost of each treatment methods will be estimated, Including the devices, disposable instruments, operating room, bed stay, imaging, laboratory, medications, retreatment and ancillary procedures.
Time Frame
throughout the study procedure, up to 3 months post-operative.
Title
Patients satisfaction
Description
A 5-point scale will be used to assess satisfaction, where 1 is unsatisfied and 5 fully satisfied.
Time Frame
throughout the study procedure, up to 3 months post-operative
Title
Surgeon's satisfaction.
Description
A 5-point scale will be used to assess satisfaction, where 1 is unsatisfied and 5 fully satisfied.
Time Frame
throughout the study procedure, up to 3 months post-operative

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adult patients (both genders) Single non-lower pole renal stone. Stone size: 10-20 mm. Stone density: > 1000 HU. Exclusion Criteria: Pregnant women. Morbid obesity. Severe orthopaedic deformities. Co-morbidities precluding general anaesthesia or prone positioning. Uncorrectable coagulation disorders. Active urinary tract infection (UTI). Stone in a calyceal diverticulum. Abnormal renal anatomy. Urinary tract obstruction distal to the stone. Concomitant pathology that needs intervention in the same setting. Advanced hydronephrosis.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Abul-fotouh Ahmed, MD
Phone
00201001066756
Email
abulfotouhahmed@yahoo.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Abul-fotouh Ahmed, MD
Organizational Affiliation
Al-Azhar University Hospitals, Cairo, Egypt
Official's Role
Principal Investigator
Facility Information:
Facility Name
Urology Department, Al-Azhar University Hospital
City
Cairo
ZIP/Postal Code
11633
Country
Egypt
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ahmed Fahim, MD
Phone
002025107333
Email
urologyhospital@gmail.com
First Name & Middle Initial & Last Name & Degree
Hassan Abdelazeim, MD

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Mini-PNL, RIRS, and ESWL for Treatment of Medium-Sized, High-Density, Non-Lower Pole, Renal Stones

We'll reach out to this number within 24 hrs